دانشگاه علوم پزشکی ایران
Iran University of Medical Sciences

A new medication to treat tinnitus

 | Post date: 2021/5/26 | 
A new medication from the human placenta introduced to treat tinnitus
A group of Iranian researchers, in collaboration with those from Russia and Germany, carried out a research project and could produce a drug from the human placenta to treat tinnitus. The results of the study in the human phase showed that the drug, as well as making the complication tolerable in patients, has improved the hearing threshold in people with progressive hearing loss.

The sensation of ringing in the ears is called tinnitus. This common condition often affects about 15-20 percent of the population. Tinnitus is not a disease, but a symptom of an underlying condition such as hearing loss due to old age, ear damage or circulatory disorders.

Although the disease has not yet been curable, the researchers at the ENT and Head Research Center of Iran University of Medical Sciences have defined a synergy research project in collaboration with several Iranian research centers and some from Germany and Russia could achieve a drug, derived from human embryos, in the animal phase, the results of which indicated that the drug was effective in treating the disease in the animal phase.

Receiving the code of ethics, the researchers entered the phase of clinical trials, the results of which indicated a cure of more than 50% in the human phase, and they hope to introduce the drug as a medication to treat the disease by performing the next phases of the subsequent trials.